Is This the End of Legal Medical Marijuana, Too?

Jeff Sessions changed an Obama-era policy on cannabis, and it could affect medical use.

A person wearing gloves prepares medical marijuana.
Nir Elias / Reuters

On Thursday, Attorney General Jeff Sessions rescinded the Cole Memorandum, an Obama-era policy that took a hands-off approach to marijuana in states where it was legal. Instead, federal prosecutors, Sessions wrote, should decide for themselves whether to crack down on marijuana businesses.

This likely spells trouble for recreational marijuana, which is now legal in eight states and Washington, D.C. The move prompted an outcry from legalization advocates. “Enforcement is up to individual U.S. Attorneys, but this is a clear directive from their boss to start going after legitimate, taxpaying businesses,” said Morgan Fox, the communications director for the Marijuana Policy Project, via email.

What’s not as clear is how this might affect medical marijuana, long considered the more acceptable cousin to recreational weed.

A provision called the Rohrabacher-Blumenauer amendment protects medical-marijuana programs in states from federal interference. But that provision expires January 19, unless the new federal spending bill renews it. It’s not clear whether it will be included in however Congress decides to fund the government next. Justice officials told the Associated Press they “would follow the law, but would not preclude the possibility of medical-marijuana-related prosecutions.”

Sessions’s memo opens up an interesting rift between antidrug Republicans and states’-rights Republicans. “Jeff Sessions has forgotten about the Constitution and the Tenth Amendment,” said Representative Dana Rohrabacher, a Republican from California and sponsor of the amendment, on a call with reporters.

“People see the impact of this stupid mindset from the 1950s and early ’60s,” he later added. “That’s what Jeff is representing, I’m afraid.”

If the Rohrabacher-Blumenauer amendment goes away, federal agents could start raiding and shutting down medical-marijuana dispensaries with renewed vigor.

Under the Bush administration, DEA agents shut down 30 to 40 medical dispensaries, sometimes raiding them even if they appeared to be lawful. Eric Holder, the attorney general under most of President Obama’s tenure, signaled he would end law-enforcement raids on legitimate medical dispensaries in 2009. Still, medical-marijuana dispensaries in New Mexico, California, Colorado, and elsewhere were being raided throughout the Obama administration, sometimes for allegedly violating rules that came with the Obama administration’s supposedly more lenient approach, like trafficking marijuana outside state lines.

“There’s no question that Obama’s the worst president on medical marijuana,” Rob Kampia, then the executive director of the Marijuana Policy Project, told Rolling Stone in 2012.

But now, 60 percent of states have a medical-marijuana program, so the pressure might be on Congress to renew the amendment. Medical marijuana is more popular than the recreational kind since some find it helps PTSD, epilepsy, and other ailments. “It’s harder for a politician to say, ‘you wounded Iraq veteran, go ahead and suffer, because we want to shut down your program,’” said Franklin Snyder, a professor of law at Texas A&M University. “It’s much easier to say, ‘you Colorado hippie potheads, we don’t want you smoking dope to get high.’”

On the call, Rohrabacher suggested that the move by Sessions would “mobilize people” and that he hopes to get a law passed that says “the federal government will respect all of the decisions of the states when it comes to cannabis.” He also said he plans to hold the president’s “feet to the fire,” since on the campaign trail Trump seemed rather neutral on marijuana.

Doug Berman, a professor of law at Ohio State University, thinks the policy change might not end up being that radical, especially if it mainly targets “bad players”—dispensary owners who don’t follow regulations. Even so, “an effort even to take a scalpel to the industry might nick the more responsible players.”

Mark Kleiman, a professor of public policy at New York University, says “the most likely practical consequence of this decision is to drive young voters to the polls this November.”

Either way, this adds to the chilling effect for an industry that already faces strict regulations and an awkward dance between state permissiveness and federal prohibition.

Would-be dispensary owners might think, Berman said, “Wow, another headache, another hurdle, another layer of uncertainty. I shouldn’t bother putting my money in this.”

Olga Khazan is a staff writer at The Atlantic. She is the author of Weird: The Power of Being an Outsider in an Insider World. She has also written for The New York Times, the Los Angeles Times, The Washington Post, and other publications. She writes a Substack on personality change.